Detalhe da pesquisa
1.
Integrative spatial analysis reveals a multi-layered organization of glioblastoma.
Cell;
187(10): 2485-2501.e26, 2024 May 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38653236
2.
Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours.
Nature;
618(7965): 598-606, 2023 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37258682
3.
Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation-Immune signature correlates with response.
Br J Haematol;
203(2): 264-281, 2023 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37539479
4.
ATR represents a therapeutic vulnerability in clear cell renal cell carcinoma.
JCI Insight;
7(24)2022 12 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36413415
5.
Therapeutic Effects of Inhibition of Sphingosine-1-Phosphate Signaling in HIF-2α Inhibitor-Resistant Clear Cell Renal Cell Carcinoma.
Cancers (Basel);
13(19)2021 Sep 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34638286
6.
Transitioning the Molecular Tumor Board from Proof of Concept to Clinical Routine: A German Single-Center Analysis.
Cancers (Basel);
13(5)2021 Mar 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33800365
7.
HIF-1α and HIF-2α differently regulate tumour development and inflammation of clear cell renal cell carcinoma in mice.
Nat Commun;
11(1): 4111, 2020 08 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32807776
8.
Personalized Clinical Decision Making Through Implementation of a Molecular Tumor Board: A German Single-Center Experience.
JCO Precis Oncol;
22018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32913998
9.
Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneity.
Nat Commun;
7: ncomms11845, 2016 06 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27291893